These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26670231)

  • 21. Histologic changes associated with talaporfin sodium-mediated photodynamic therapy in rat skin.
    Moy WJ; Yao J; de Feraudy SM; White SM; Salvador J; Kelly KM; Choi B
    Lasers Surg Med; 2017 Oct; 49(8):767-772. PubMed ID: 28489260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy.
    Chen B; Pogue BW; Hoopes PJ; Hasan T
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1216-26. PubMed ID: 15752904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
    Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin).
    Akens MK; Hardisty MR; Wilson BC; Schwock J; Whyne CM; Burch S; Yee AJ
    Breast Cancer Res Treat; 2010 Jan; 119(2):325-33. PubMed ID: 19263216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of vascular effect of Photodynamic Therapy in chorioallantoic membrane using different photosensitizers.
    Buzzá HH; Silva LV; Moriyama LT; Bagnato VS; Kurachi C
    J Photochem Photobiol B; 2014 Sep; 138():1-7. PubMed ID: 24892978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
    Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC
    Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of new chlorin derivatives as potential photosensitizers for photodynamic therapy.
    Asano R; Nagami A; Fukumoto Y; Yazama F; Ito H; Sakata I; Tai A
    Bioorg Med Chem; 2013 Apr; 21(8):2298-2304. PubMed ID: 23477944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationships of mono-substituted trisulfonated porphyrazines for the photodynamic therapy (PDT) of cancer.
    Cauchon N; Ali H; Hasséssian HM; van Lier JE
    Photochem Photobiol Sci; 2010 Mar; 9(3):331-41. PubMed ID: 20221459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photodynamic therapy with PAD-S31, a new hydrophilic chlorin photosensitizer, in an orthotopic rat bladder tumor model.
    Asanuma H; Arai T; Morimoto Y; Kawauchi S; Satoh H; Seguchi K; Kikuchi M; Murai M
    J Urol; 2005 Nov; 174(5):2016-21. PubMed ID: 16217385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photodynamic therapy using a protease-mediated theranostic agent reduces cathepsin-B activity in mouse atheromata in vivo.
    Shon SM; Choi Y; Kim JY; Lee DK; Park JY; Schellingerhout D; Kim DE
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1360-5. PubMed ID: 23539220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenic cell death due to a new photodynamic therapy (PDT) with glycoconjugated chlorin (G-chlorin).
    Tanaka M; Kataoka H; Yano S; Sawada T; Akashi H; Inoue M; Suzuki S; Inagaki Y; Hayashi N; Nishie H; Shimura T; Mizoshita T; Mori Y; Kubota E; Tanida S; Takahashi S; Joh T
    Oncotarget; 2016 Jul; 7(30):47242-47251. PubMed ID: 27363018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A next-generation bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis.
    Nishie H; Kataoka H; Yano S; Kikuchi JI; Hayashi N; Narumi A; Nomoto A; Kubota E; Joh T
    Oncotarget; 2016 Nov; 7(45):74259-74268. PubMed ID: 27708235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical Study of Antineoplastic Sinoporphyrin Sodium-PDT via In Vitro and In Vivo Models.
    Shi R; Li C; Jiang Z; Li W; Wang A; Wei J
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28085075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photodynamic Therapy Using Novel Glucose-conjugated Chlorin Increases Apoptosis of Cholangiocellular Carcinoma in Comparison with Talaporfin Sodium.
    Murakami G; Nanashima A; Nonaka T; Tominaga T; Wakata K; Sumida Y; Akashi H; Okazaki S; Kataoka H; Nagayasu T
    Anticancer Res; 2016 Sep; 36(9):4493-501. PubMed ID: 27630287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo photodynamic characteristics of the near-infrared photosensitizer 5,10,15,20-tetrakis(M-hydroxyphenyl) bacteriochlorin.
    Rovers JP; de Jode ML; Rezzoug H; Grahn MF
    Photochem Photobiol; 2000 Sep; 72(3):358-64. PubMed ID: 10989607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor histopathology following new sensitizers: dithiaporphyrin- and sulfoxaporphyrin-mediated photodynamic therapy.
    Symonowicz K; Ziólkowski P; Chmielewski P; Latos-Grazynski L; Rabczynski J; Osiecka BJ; Milach J
    Anticancer Res; 1999; 19(6B):5385-91. PubMed ID: 10697566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antibacterial effect of sinoporphyrin sodium photodynamic therapy on Staphylococcus aureus planktonic and biofilm cultures.
    Mai B; Wang X; Liu Q; Leung AW; Wang X; Xu C; Wang P
    Lasers Surg Med; 2016 Apr; 48(4):400-8. PubMed ID: 26749227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-specific systemic immune suppression induced by photodynamic treatment of lymph node cells with bacteriochlorin a.
    van Iperen HP; Schuitmaker HJ; Beijersbergen van Henegouwen GM
    J Photochem Photobiol B; 1995 Jun; 28(3):197-202. PubMed ID: 7623184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved formulation of photosensitizer chlorin e6 polyvinylpyrrolidone for fluorescence diagnostic imaging and photodynamic therapy of human cancer.
    Chin WW; Heng PW; Thong PS; Bhuvaneswari R; Hirt W; Kuenzel S; Soo KC; Olivo M
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1083-93. PubMed ID: 18396019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photodynamic therapy using a novel photosensitizer, EC036, is more effective compared with ATX-S10(Na) photodynamic therapy.
    Takahashi H; Nakajima S; Asano R; Nakae Y; Sakata I; Iizuka H
    J Dermatol Sci; 2009 Aug; 55(2):130-2. PubMed ID: 19398306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.